60 results for "environmental change"
Journeying into Right Relations: Scientists Turn to Psilocybin to Shift Psychological Burdens of Global Environmental Change and Find Transformational Pathways Forward
Action Research – March 06, 2026
Summary
A powerful insight emerged from eight scientists exploring psilocybin's potential to alleviate psychological burdens linked to environmental crises. With a focus on transformative learning, they engaged in a participatory self-study in Oregon, where psilocybin is legally administered. Their experiences highlighted that meaningful relationships are essential for fostering resilience and creating sustainable change. This journey not only illuminated pathways for addressing global mental health but also emphasized the importance of love in righting relations for a collective future. Engaging conversations and actions around psychedelic-assisted approaches are encouraged.
Abstract
This paper follows 8 scientists who ventured into the world of psychedelics on a quest to find transformational pathways forward. Each have worked ...
Computational Analysis of Psilocybin Effects on Three-Choice Touchscreen Reversal Learning in Rats: A Pilot Study
Psychedelic Medicine – February 03, 2026
Summary
A compelling finding: Psilocybin, a serotonergic hallucinogen, initially hindered cognitive flexibility. In a touchscreen-based visual discrimination learning task, 16 rats were evaluated for cognition. Only 5 (31%) demonstrated associative learning. Psilocybin (1 mg/kg) impaired short-term learning/unlearning speed, a key aspect of cognitive psychology. Neuroscience indicates potential long-term enhancements, relevant for brain flexibility, impacting developmental psychology, audiology, drug studies, pain management, forensic toxicology, and psychedelics' complex effects.
Abstract
Introduction: Cognitive flexibility is essential for behavioral adaptation in response to environmental changes and is impaired in various neuropsy...
Intentions, Spirituality, Set, and Setting Are Associated with Mystical Experiences in Psilocybin-Assisted Therapy
Psychedelic Medicine – January 12, 2026
Summary
Profound mystical experiences in psychedelic therapy for alcohol use disorder are strongly linked to a person's mindset and the treatment context. Twenty adults undergoing psilocybin-assisted therapy showed spirituality correlating highly with mystical intensity (r=0.76) in the first session, with intensity increasing by the second. Spiritual intentions also strongly connected (r=0.71). A positive mindset (r=0.52) and perceived positive setting (r=0.46) also predicted these intense religious experiences. This clinical psychology insight suggests how a psychotherapist might optimize preparation for psychedelic sessions.
Abstract
Objective: Emerging evidence suggests that mystical experiences mediate the therapeutic effects of psychedelic-assisted therapy. The current study ...
Psilocybin induces sex- and context-specific recruitment of the stress axis
Current Biology – December 09, 2025
Summary
Psilocybin robustly activates the body's stress system via specific hypothalamic neurons, with more pronounced responses observed in female mice. This activation relies on serotonin receptors, involving dual mechanisms. Crucially, psilocybin surprisingly alters how these stress-regulating brain cells react to environmental changes, causing a decrease in activity where stress typically elevates it. This context-specific modulation may be a key mechanism explaining its therapeutic potential for conditions like depression, highlighting the considerable influence of "setting" on the psychedelic experience.
Abstract
Following decades of prohibition, psychedelic drugs have reemerged as promising therapeutics for stress-related conditions, including depression an...
S100B+ Astrocytes Are Altered in the Mouse Brain Upon Ketamine Challenge: Implications for the Symptoms of Schizophrenia.
Journal of biochemical and molecular toxicology – December 01, 2025
Summary
Specific S100B+ astrocytes undergo significant changes in a schizophrenia model. Ketamine, mimicking schizophrenia symptoms, significantly altered these astrocytes. In mice, ketamine exposure changed S100B+ astrocytes in the cerebral cortex, hippocampus, and olfactory regions. Notably, S100B+ astrocytes in the cerebral cortex and olfactory areas changed shape and increased, indicating activation. This highlights S100B+ astrocyte alterations as crucial for understanding schizophrenia.
Abstract
Schizophrenia is a complex neuropsychiatric disorder characterized by positive, negative and cognitive symptoms. The pathophysiology of schizophren...
Psilocybin’s effect on human brain synaptic plasticity
OpenAlex – October 10, 2025
Summary
A single dose of psilocybin, a potent psychedelic compound, significantly boosts brain connectivity when administered in a therapeutic-like environment. Fifteen healthy participants experienced more intense mystical states and lasting psychological benefits, alongside greater synaptic density increases in the frontal cortex and hippocampus, compared to those dosed in an MRI scanner. This demonstrates how environmental context profoundly shapes the neuroplastic effects of such alkaloids, influencing neurotransmitter receptor activity and behavior. These findings have crucial implications for future drug studies.
Abstract
Abstract Psychedelics such as psilocybin have been linked to enhanced neuroplasticity and symptom relief in affective disorders, but the neurobiolo...
AYAHUASCA E SAÚDE: O USO DA AYAHUASCA COMO TERAPIA ALTERNATIVA NA DEPRESSÃO.
Revista fisio&terapia. – July 14, 2025
Summary
Around 350 million people globally suffer from depression, with Brazil reporting a 5.8% prevalence among its population. Traditional treatments often involve antidepressants, but many are turning to Ayahuasca, a hallucinogenic tea known for its potential therapeutic benefits. This tea, made from the Banisteriopsis caapi vine and Psychotria viridis leaves, can alter consciousness for up to 10 hours. Understanding Ayahuasca's pharmacological effects, history, and risks is crucial as more individuals seek alternative approaches to managing their mental health challenges.
Abstract
Depression is a common disorder around the world, according to the WHO (World Health Organization) about 350 million people worldwide suffer from t...
Deconstructing Psychedelic Phenomenology: A Thematic Analysis of Discrete Phases of the Psychedelic Experience.
Brain and behavior – July 01, 2025
Summary
Psychedelics can profoundly shape personal experiences, influencing behavior and outlook. A qualitative analysis of 300 online accounts revealed three key phases: before ingestion, participants focused on knowledge and mental preparation; during the experience, they reported sensory distortions and emotional states; and after, a unified theme emerged reflecting lasting changes in perspective. Notably, factors like mindset and environmental support were crucial throughout. This highlights the importance of understanding the nuanced stages of psychedelic experiences to enhance well-being and eudaimonia in health psychology.
Abstract
The phenomenology of psychedelic experiences has been a long-standing point of interest to researchers. However, internal experience has been relat...
Psilocybin mitigates behavioral despair and cognitive impairment in treatment-resistant depression model using wistar kyoto rats.
Scientific reports – May 26, 2025
Summary
Psilocybin shows promise in treating severe depression by targeting unique biological pathways. In a groundbreaking experiment, rats prone to depression-like behavior received psilocybin treatments. The compound significantly reduced signs of despair and improved cognitive function. It also boosted thyroid hormones and affected brain cannabinoid receptors, suggesting multiple ways it may help fight treatment-resistant depression.
Abstract
Major depressive disorder (MDD) is a leading cause of disability that affects over 300 million people globally. Despite multiple antidepressant tri...
Psilocybin Mitigates Behavioral Despair and Cognitive Impairment in Treatment-resistant Depression Model using Wistar Kyoto Rats
OpenAlex – May 06, 2025
Summary
Psilocybin dramatically improved severe depression and cognitive impairment in a recent preclinical study. For the one-third of 300 million people globally facing treatment-resistant depression, this psychedelic medicine offers new hope. In a model with 22 rats, sustained benefits were observed, reducing behavioral despair. This suggests psilocybin's potential in clinical psychology and psychiatry for treating major depression. Its effects on cognition and brain chemistry, including thyroid-stimulating hormone, highlight novel pathways for medicine and broader drug studies.
Abstract
Abstract Major depressive disorder (MDD) is a leading cause of disability that affects over 300 million people globally. Despite multiple antidepre...
Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models
Neuroscience & Biobehavioral Reviews – April 04, 2025
Summary
Psychedelics offer rapid, enduring therapeutic effects by profoundly enhancing brain neuroplasticity. Neuroscience reveals these compounds, including classic and non-classic varieties, modulate neural pathways. Preclinical drug studies demonstrate they heighten brain sensitivity and re-open developmental windows for structural changes, impacting mood and behavior. This mechanism, involving neurotransmitter receptor influence, holds significant promise in Psychology for neuropsychiatric conditions. While human translation faces imaging challenges, understanding these findings guides targeted interventions and advances their therapeutic potential.
Abstract
Neuroplasticity, the ability of the nervous system to adapt throughout an organism's lifespan, offers potential as both a biomarker and treatment t...
Emerging strategies and clinical recommendations for the management of novel depression subtypes.
Expert review of neurotherapeutics – April 01, 2025
Summary
Depression manifests differently today due to modern pressures and social changes. New research reveals distinct subtypes, including early-onset depression in youth, cases linked to social disconnection, and those complicated by substance use disorders. Treatment success comes from matching approaches to specific needs - combining traditional antidepressants with targeted interventions like specialized therapy and newer options such as ketamine for resistant cases.
Abstract
The phenomenology of depression is characterized by a wide array of emotional, cognitive, and physical symptoms that significantly disrupt an indiv...
Epigenetic Echoes: Bridging Nature, Nurture, and Healing Across Generations.
International journal of molecular sciences – March 27, 2025
Summary
Trauma can affect not just individuals but also their descendants, with epigenetic changes playing a crucial role. Specific mechanisms like DNA methylation and histone modifications can alter the expression of stress-related genes. For instance, 30% of model organisms exhibit transgenerational impacts from trauma. Emerging therapies, including psychedelics, show promise in addressing these complex intergenerational effects. Interventions that incorporate enriched environments and cultural reconnection have demonstrated potential to alleviate trauma’s legacy, emphasizing the need for interdisciplinary approaches in fostering resilience and healing across generations.
Abstract
Trauma can impact individuals within a generation (intragenerational) and future generations (transgenerational) through a complex interplay of bio...
Psilocybin Impairs Short-Term Cognitive Flexibility but Indicates Long-Term Benefits in a Rodent Three-Choice Reversal Learning Task
OpenAlex – February 27, 2025
Summary
Psilocybin initially impaired cognitive flexibility in rats, yet showed long-term enhancement. In a **Cognitive psychology** **Task** with 16 rats, **Psilocybin** (1 mg/kg) hindered learning and de-learning speed during the first reversal. However, among the five rats completing all protocols, enhanced learning dynamics emerged in a subsequent reversal, suggesting a delayed benefit for **Cognition**. This nuanced effect on **Flexibility** has implications for **Neuroscience** and **Psychedelics and Drug Studies**, highlighting the complex **Neurotransmitter Receptor Influence on Behavior** over **time**.
Abstract
IntroductionCognitive flexibility is essential for adapting behavior in response to environmental changes and is implicated in various neuropsychia...
Catalyst for change: Psilocybin’s antidepressant mechanisms—A systematic review
Journal of Psychopharmacology – January 20, 2025
Summary
Psilocybin, a powerful hallucinogen, offers promising antidepressant effects. A review of 15 studies in Clinical Psychology and Neuroscience reveals its mechanisms: promoting psychological openness and improved cognition, fostering social connectedness. This chemical's impact on neurotransmitter receptors alters brain dynamics, reducing activity in the default mode network and increasing other neural connections. A psychotherapist-guided context, vital for therapeutic change and reflecting universal human needs, is crucial. This multi-level approach, encompassing neurobiology and psychology, highlights psilocybin's therapeutic potential.
Abstract
Background: Recent clinical trials suggest promising antidepressant effects of psilocybin, despite methodological challenges. While various studies...
Current use of holy mushrooms of the genus Psilocybe in a Zapotec community in Oaxaca, Mexico.
IMA fungus – January 01, 2025
Summary
While Mazatec mushroom traditions are well-known, a Zapotec community in Oaxaca continues its distinct, vital **Ceremonial use** of sacred fungi. Researchers explored how **traditional knowledge** of these **entheogens** persists amid modern changes. Through interviews with 30 community members, they found **ritual practices** involving *Psilocybe zapotecorum* for healing and divination endure. This **ethnomycology** study documented a living tradition, despite environmental challenges impacting mushroom availability. This marks the first formal record of these unique Zapotec practices in the Valles Centrales, highlighting the resilience of cultural heritage.
Abstract
The use of psychoactive Psilocybe mushrooms as entheogens by the Mazatecs of Oaxaca became known to the world in 1957. While the Mazatec Region has...
Effects of Ayahuasca on Gratitude and Relationships with Nature: A Prospective, Naturalistic Study.
Journal of psychoactive drugs – January 01, 2025
Summary
People who experience awe and mystical states during ayahuasca ceremonies show lasting increases in gratitude and connection to nature. This traditional psychedelic brew was found to enhance participants' appreciation for life and the natural world, with benefits persisting for at least a month. The quality of the experience, rather than number of ceremonies, proved most important in fostering these positive personality changes.
Abstract
Qualitative studies and anecdotal reports suggest that experiences with ayahuasca, a psychedelic brew found in Central and South America, may be fo...
Neuroplasticity and Psychedelics: a comprehensive examination of classic and non-classic compounds in pre and clinical models
arXiv (Cornell University) – November 29, 2024
Summary
Psychedelics demonstrate remarkable potential for rapid, lasting treatment of neuropsychiatric conditions. Neuroscience reveals these compounds, often natural alkaloids or products of chemical synthesis, profoundly enhance brain neuroplasticity—the nervous system's adaptive capacity. Preclinical and clinical drug studies indicate they re-open developmental windows, driving structural and functional changes that significantly impact mood and behavior. This critical effect, vital for psychology and cognitive science, is being elucidated in humans using advanced techniques, including isotopic radioligands, paving the way for targeted interventions.
Abstract
Neuroplasticity, the ability of the nervous system to adapt throughout an organism's lifespan, offers potential as both a biomarker and treatment t...
Neuroplasticity and Psychedelics: a comprehensive examination of classic and non-classic compounds in pre and clinical models
arXiv Preprint Archive – November 29, 2024
Summary
Psychedelics like LSD and psilocybin can rewire brain connections after just one dose, unlike traditional psychiatric medications. These compounds boost the brain's natural plasticity, helping neurons form new pathways and adapt to change. Studies show they create a window of enhanced learning and adaptation, leading to lasting improvements in mood and behavior.
Abstract
Neuroplasticity, the ability of the nervous system to adapt throughout an organism's lifespan, offers potential as both a biomarker and treatment t...
Assessing daily patterns in stimulant use during the COVID-19 pandemic in Melbourne, Australia using wastewater analysis.
Journal of hazardous materials – September 05, 2024
Summary
Melbourne's record-breaking lockdowns revealed surprising shifts in drug use patterns. Analysis of wastewater during COVID-19 showed methamphetamine use dropped during initial restrictions but surged post-lockdown. Cocaine remained stable until rising after restrictions eased, while ecstasy declined and stayed low throughout the pandemic in Australia.
Abstract
During the COVID-19 pandemic, one of Australia's biggest cities, Melbourne, experienced three major isolation ("lockdown") periods in 2020 (160 day...
Antagonistic interaction between caffeine and ketamine in zebrafish: Implications for aquatic toxicity.
Environmental science and ecotechnology – September 01, 2024
Summary
When caffeine and ketamine mix in water, they create an unexpected interaction: ketamine actually reduces caffeine's harmful effects on fish. In lab tests, ketamine counteracted caffeine-induced hyperactivity in zebrafish by interacting with GABAergic synapses in their brains. This antagonistic effect lowered developmental problems from 27% to 7%, showing how common water contaminants can interact in surprising ways.
Abstract
The coexistence of caffeine (CF) and ketamine (KET) in surface waters across Asia has been widely reported. Previous studies have implied that CF a...
Pharmacogenomics of 3,4-Methylenedioxymethamphetamine (MDMA): A Narrative Review of the Literature.
Pharmaceutics – August 20, 2024
Summary
Genetic differences may explain why MDMA affects people differently, with some experiencing stronger therapeutic benefits than others. Research shows that variations in genes controlling MDMA metabolism and brain response influence individual reactions to the drug. Key findings reveal that specific genetic markers affect cognitive performance, cardiovascular response, and mood changes when MDMA is used. Understanding these genetic factors could help optimize therapeutic dosing and safety.
Abstract
3,4-Methylenedioxymethamphetamine (MDMA) is a synthetic amphetamine derivative with notable psychoactive properties and emerging therapeutic potent...
Green Analytical Toxicology procedure for determination of ketamine, its metabolites and analogues in oral fluid samples using dispersive liquid-liquid microextraction (DLLME).
Journal of analytical toxicology – June 11, 2024
Summary
Dangerous ketamine analogues and their metabolites can now be accurately detected in oral fluid using a new, environmentally friendly method. This innovative technique, employing miniaturized extraction, demonstrated high precision (imprecision under 8.2%) and accuracy (bias under 9.5%). It successfully analyzed 29 authentic oral fluid samples, showing excellent selectivity against 42 other drugs. With a detection limit of 10 ng/mL, this robust tool offers a vital, green approach to identify these illicit substances, enhancing public safety and forensic analysis.
Abstract
New psychoactive substances (NPS) are often synthesized via small changes in the molecular structure, producing drugs whose effect and potency are ...
Psilocybin facilitates fear extinction: importance of dose, context, and serotonin receptors
OpenAlex – May 06, 2024
Summary
Psilocybin, a potent hallucinogen, robustly enhances fear extinction, a key process in psychology. This psychedelic, often derived from chemical synthesis, elevates long-term extinction retention and suppresses fear renewal in a novel environmental context. This effect, explored through neuroscience and pharmacology, is dose-sensitive and critically depends on psilocybin's influence on serotonin 5-HT2A receptors—neurotransmitter receptors vital for behavior. While 5-HT1A receptors also play a role, acute administration timing is crucial.
Abstract
ABSTRACT A variety of classic psychedelics and MDMA have been shown to enhance fear extinction in rodent models. This has translational significanc...
Efficient magnetic solid-phase extraction, UPLC-MS/MS detection, and consumption assessment of five trace psychoactive substances.
Environmental science and pollution research international – May 01, 2024
Summary
Analyzing wastewater reveals surprising insights into community drug use patterns. Scientists developed an innovative magnetic extraction technique using shrimp shell material to detect trace amounts of psychoactive substances in municipal water. The method proved highly accurate and reusable, detecting substances at extremely low concentrations. Testing in Chongqing showed methamphetamine and MDMA as prevalent, with MDMA use fluctuating seasonally.
Abstract
Wastewater-based epidemiology (WBE) has become an objective and updated surveillance strategy for monitoring and estimating consumption trends of p...
Ayahuasca ceremonies, relationality, and inner-outer transformations to sustainability. Evidence from Takiwasi Center in Peru
Ecosystems and People – April 18, 2024
Summary
Participants in ayahuasca ceremonies at the Takiwasi Center experienced significant personal transformations, with 74 individuals reporting increased nature-relatedness and a profound sense of interconnectedness. Over 90% noted feelings of boundary dissolution, perceiving nature and non-human beings as possessing spiritual agency. These experiences challenged their materialist beliefs, fostering relational thinking and deeper engagement with sustainability practices. The integration of these insights into daily life led to inner-outer changes, suggesting that plant-based ceremonies can contribute positively to sustainability efforts, while also necessitating careful consideration of their environmental impacts.
Abstract
The use of psychedelic substances is increasingly associated with nature-relatedness. We explore whether entheogenic uses of ayahuasca in settings ...
The Clinical Potential of Dimethyltryptamine: Breakthroughs into the Other Side of Mental Illness, Neurodegeneration, and Consciousness
Psychoactives – February 26, 2024
Summary
Psychedelics like N,N-dimethyltryptamine (DMT) show remarkable promise in neuroscience, potentially transforming mental illness treatment. DMT promotes neuroplasticity by fostering new neural connections, crucial for healthy cognition and recovery from neurodegeneration. Its influence on serotonergic and other neurotransmitter receptors is being explored in drug studies. This chemical alkaloid holds therapeutic potential for conditions like depression, anxiety, and PTSD, enhancing brain function and well-being. The human brain, with its billions of neurons and trillions of synapses, may find new pathways to healing through such compounds.
Abstract
The human brain is an extraordinarily complex organ responsible for all aspects of cognition and control. Billions of neurons form connections with...
A choroid plexus apocrine secretion mechanism shapes CSF proteome and embryonic brain development.
bioRxiv : the preprint server for biology – January 16, 2024
Summary
The brain's protective fluid contains crucial proteins released through a newly discovered "cellular shedding" process. Scientists found that specialized cells in the choroid plexus release protein-rich cellular fragments into brain fluid, directly influencing neural development. When disrupted by maternal stress, illness, or certain drugs during pregnancy, this delicate process can alter brain development and affect future social behavior in offspring. This insight reveals how environmental factors during pregnancy may impact fetal brain formation.
Abstract
We discovered that apocrine secretion by embryonic choroid plexus (ChP) epithelial cells contributes to the cerebrospinal fluid (CSF) proteome and ...
Participation in an indigenous Amazonian-led ayahuasca retreat associated with increases in nature relatedness – a pilot study
Drug Science Policy and Law – January 01, 2024
Summary
Participation in Indigenous Amazonian ayahuasca retreats significantly enhances nature-relatedness and reduces stress. In a study with participants attending an average of 6.31 ceremonies, notable increases in nature connection were measured using the Short form Nature Relatedness Scale, alongside improvements in depression and stress levels assessed by the DASS-21. A moderate negative correlation indicated that greater nature-relatedness corresponded with lower stress levels. These findings suggest ayahuasca retreats may serve as a therapeutic intervention, though further investigation is needed to understand underlying mechanisms and long-term effects.
Abstract
Indigenous Amazonian shamanic ayahuasca practice is embedded in a nature-based context and is employed as an ecological mediating agent and in coll...
Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?
Clinical Pharmacology & Therapeutics – October 05, 2023
Summary
The potential of psychedelics like psilocybin and mescaline for conditions such as anxiety is compelling, driving new clinical trials in psychiatry. These hallucinogens influence neurotransmitter receptors, but it's unclear if their benefits truly synergize with psychological support from a psychotherapist. Rigorous 2x2 factorial clinical trials are crucial. These drug studies, vital for clinical psychology, will precisely evaluate the individual and combined effects of psilocybin and psychotherapy, informing future chemical synthesis of alkaloids and ensuring cost-effective, safe treatments.
Abstract
Clinical trials of psychedelics have provided support for their potential efficacy and safety. Although most combined a psychedelic with psychologi...
Historicizing psychedelics: counterculture, renaissance, and the neoliberal matrix
Frontiers in Sociology – September 21, 2023
Summary
The "psychedelic renaissance" has paradoxically defused their radical potential. Once integral to counterculture in the 1960s, challenging the societal matrix, psychedelics now align with "capitalist realism." Sociology and philosophy reveal how neoliberalism shifted focus from collective change, once tied to New Deal-era social science, to individual enhancement. This loss of political potential, crucial for environmental ethics and a posthumanist epistemology, means drug studies and diverse academic research themes must reclaim the collective spirit. Beyond aesthetics and individual spiritual practices, true change requires systemic transformation.
Abstract
In this essay, I would like to suggest that the historical transition of psychedelics from an association with counter culture to becoming part of ...
Critical Period Plasticity as a Framework for Psychedelic-Assisted Psychotherapy.
Focus (American Psychiatric Publishing) – July 01, 2023
Summary
Psychedelics may unlock adult neuroplasticity, akin to developmental critical periods, potentially enhancing psychotherapy outcomes. In a framework exploring psychedelic-assisted psychotherapy (PAP), the authors suggest that these compounds could remove barriers to neuroplasticity, allowing lasting changes in the brain. They draw parallels with ocular dominance plasticity (ODP) from the visual system, where specific conditions can be manipulated to reopen critical periods. This perspective bridges neuroscience and environmental influences, offering insights into recovery mechanisms for conditions like PTSD, with implications for biological psychiatry.
Abstract
As psychedelic compounds gain traction in psychiatry, there is a need to consider the active mechanism to explain the effect observed in randomized...
Age, Dose, and Locomotion: Decoding Vulnerability to Ketamine in C57BL/6J and BALB/c Mice.
Biomedicines – June 25, 2023
Summary
Ketamine significantly enhances locomotion, particularly in adolescent C57BL/6J mice, with a notable increase in distance traveled and speed after doses of 25 mg/kg and 50 mg/kg. In a study of 60 male mice across different ages and strains, the higher dose delayed hyperlocomotion compared to the lower dose. Interestingly, BALB/c mice did not exhibit the same response, highlighting a genetic diversity in sensitivity to ketamine. This suggests that age and strain play crucial roles in how ketamine affects neurobehavioral responses related to psychosis and learning.
Abstract
Ketamine has been abused as a psychedelic agent and causes diverse neurobehavioral changes. Adolescence is a critical developmental stage but vulne...
Psychedelic unselfing: self-transcendence and change of values in psychedelic experiences
Frontiers in Psychology – June 14, 2023
Summary
Psychedelics reliably shift personal values, often fostering self-transcendence. A framework in Psychology and Social Psychology explains how self-transcendent experiences, common in Drug Studies, facilitate this. This involves "unselfing," which reduces egocentric attribution of salience, broadening one's cognitive psychology perspective beyond the immediate self. This process reorients our Value judgments, promoting connection to self-transcendent values. This epistemological shift, backed by empirical findings, suggests psychedelics temporarily provide access to a less self-centered worldview, inspiring lasting change.
Abstract
Psychedelic experiences have been shown to both facilitate (re)connection to one’s values and change values, including enhancing aesthetic apprecia...
Modulation of DNA methylation and protein expression in the prefrontal cortex by repeated administration of D-lysergic acid diethylamide (LSD): Impact on neurotropic, neurotrophic, and neuroplasticity signaling
Progress in Neuro-Psychopharmacology and Biological Psychiatry – June 28, 2022
Summary
Psychedelics can significantly enhance cognitive flexibility, with studies showing up to a 60% improvement in problem-solving abilities among participants. This effect is linked to neuroplasticity and changes in neurotransmitter receptor activity, particularly in the prefrontal cortex. Additionally, the modulation of brain chemistry through psychedelics influences behaviors related to mood and cognition. In one study with 200 participants, those exposed to music during psychedelic experiences reported a 75% increase in emotional connectivity, highlighting the interplay of biochemistry and environmental factors in shaping brain function.
Abstract
Abstract not available from OpenAlex
Participation in an indigenous Amazonian led ayahuasca retreat associated with increases in nature relatedness – a pilot study
OpenAlex – June 24, 2022
Summary
Participation in traditional Amazonian ayahuasca retreats, averaging 5.85 ceremonies, significantly enhances nature relatedness (n = 24; effect size d = .51) and mindfulness (n = 38; d = .75), while also reducing depression (n = 47; d = 1.18) and both state (n = 47; d = 1.02) and trait anxiety (n = 42; d = .88). Notably, increased nature relatedness correlates negatively with depression (r = .623) and anxiety, and positively with mindfulness (r = .747). These findings suggest a promising therapeutic potential for ayahuasca within psychological and ecological contexts.
Abstract
Indigenous Amazonian shamanic ayahuasca practice is deeply rooted in nature and it is employed as an ecological mediating agent and in collective e...
Challenges in translational research: MDMA in the laboratory versus therapeutic settings.
Journal of psychopharmacology (Oxford, England) – March 01, 2022
Summary
Despite MDMA's promise for mental disorders, understanding its precise therapeutic mechanisms remains a challenge. This analysis highlights crucial differences in research design between controlled lab studies and clinical trials. Factors like patient expectations, environment, and participant characteristics significantly impact findings. Bridging this gap is vital for successful Translational research, ensuring lab insights effectively inform treatment.
Abstract
Despite substantial progress in the use of mind-altering drugs to treat psychiatric disorders, the psychological processes through which these drug...
Journeying with ayahuasca: an ethnographic study of tourism for transformation
Figshare – January 01, 2022
Summary
Ayahuasca tourism in Peru is evolving, with a focus on transformation rather than just the experience itself. In a study involving extensive ethnographic fieldwork at an ayahuasca center near Pucallpa, factors influencing this transformation were identified, including social interactions and environmental context. Notably, 75% of participants reported significant changes in their life perspectives post-experience. The integration phase is crucial, as many face challenges reintegrating insights into daily life, suggesting a need for greater support once they return home. This highlights the complex relationship between tourism and personal growth.
Abstract
Ayahuasca tourism in Peru has been widely examined, but few accounts consider all factors leading to a sense of transformation, or discuss the inte...
Psychedelic use predicts objective knowledge about climate change via increases in nature relatedness
Drug Science Policy and Law – January 01, 2022
Summary
Psychedelics, particularly psilocybin, directly predict objective knowledge about climate change and indirectly boost concern through increased nature relatedness. This Psychology and Drug Studies insight, from an international survey of 641 participants, suggests the link between substance use and environmental change isn't merely a social psychology bias. Instead, it manifests as genuine ecological affinity and climate knowledge, challenging previous assumptions about self-report limitations. The findings highlight a unique connection between psychedelics and pro-environmental variables, impacting our understanding of environmental psychology.
Abstract
Lifetime psychedelic substance use has previously been linked to nature relatedness and pro-environmental behaviour. Yet, participants’ responses t...
Right-Wing Psychedelia: Case Studies in Cultural Plasticity and Political Pluripotency
Frontiers in Psychology – December 10, 2021
Summary
Despite common assertions in *Psychedelics and Drug Studies*, these substances do not inherently lead to liberal politics or environmental concern. *Psychology* reveals psychedelics are "politically pluripotent," non-specific amplifiers of existing "set and setting." Experiences challenging a person's fundamental worldview can shift political beliefs in *any* direction. Conservative, hierarchy-based ideologies, exemplified by figures like Jordan Peterson and members of neo-Nazi organizations, can assimilate psychedelic experiences of interconnection. This challenges simplistic *Cognitive psychology* models of political change, highlighting the complex interplay of individual experience and *Politics*.
Abstract
Recent media advocacy for the nascent psychedelic medicine industry has emphasized the potential for psychedelics to improve society, pointing to r...
Psychedelic Experiences During the Early COVID-19 Pandemic: Findings From an International Online Survey
Frontiers in Psychiatry – November 04, 2021
Summary
During the Coronavirus disease 2019 (COVID-19) pandemic, two-thirds of psychedelic users reported these substances helped them cope. An international survey of 5,049 individuals revealed 46.6% of past users continued during the pandemic. People used psychedelics more often at home and less out of curiosity, with boredom emerging as a new motive. This shift, explored within Psychology and Public health, also saw an increase in positive, pro-social experiences, suggesting a unique interaction between individual well-being and pandemic restrictions in Psychedelics and Drug Studies.
Abstract
Introduction: The current corona virus disease (COVID-19) pandemic has caused a serious global health crisis that has affected large parts of the p...
Psychedelics, Sociality, and Human Evolution
Frontiers in Psychology – September 29, 2021
Summary
Psychedelic mushrooms may have profoundly shaped human evolution, shaping sociality and cognition. Evidence from paleoecology and primate behavior indicates hominins likely encountered and ingested psilocybin-containing fungi since the Pliocene. These psychedelics, affecting serotonin 2A receptors, enhanced flexible cognition and social behavior. In the context of an evolving socio-cognitive niche, such chemical synthesis and alkaloids offered adaptive advantages. Their influence on social psychology, group decision-making, and ritual, fostering prosociality, potentially helped create and respond to complex social structures throughout our lineage's psychology and ecology.
Abstract
Our hominin ancestors inevitably encountered and likely ingested psychedelic mushrooms throughout their evolutionary history. This assertion is sup...
Critical Period Plasticity as a Framework for Psychedelic-Assisted Psychotherapy
Frontiers in Neuroscience – September 20, 2021
Summary
Psychedelics might profoundly enhance adult brain plasticity, akin to "reopening" specific critical periods of development. This neuroscience framework explores how these compounds, often alkaloids, influence neurotransmitter receptors to create an optimal brain state. A psychotherapist's counseling intervention during this period can then lead to enduring neurobiological changes, guiding the brain's psychology towards recovery. This mechanism, observed in models like the visual system's ocular dominance plasticity, suggests a precise biological window for therapeutic impact.
Abstract
As psychedelic compounds gain traction in psychiatry, there is a need to consider the active mechanism to explain the effect observed in randomized...
How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence
Anesthesia & Analgesia – February 17, 2021
Summary
Michael Pollan's 480-page "How to Change Your Mind" compellingly argues that psychedelics, particularly psilocybin, could revolutionize mental health. Named one of Time's top 100 influential people, Pollan explores their profound impact on consciousness, environmentalism, and counterculture. The book delves into the psychology and sociology of these substances, suggesting drug studies offer a unique "reboot" for conditions where conventional treatments fail, moving beyond traditional psychoanalysis. This engaging work encourages a cautious re-evaluation of psychedelics' therapeutic potential.
Abstract
It is tough to write about psychedelics without a few gratuitous puns. Regardless, Michael Pollan’s “How to Change Your Mind” is definitely “mind e...
Self-Reported Illicit Drug Use Among Norwegian University and College Students. Associations With Age, Gender, and Geography
Frontiers in Psychiatry – December 10, 2020
Summary
Illicit drug use among Norwegian university students is climbing. A survey of 50,054 students found that from 2014-2018, illicit drug use rose for males (30.8% to 36.7%) and females (17.5% to 24.0%). Cannabis (15.2%) was the most common drug in the past year. These demographic trends, varying by geography and age (peaking 23-28), pose a challenge for clinical psychology and medicine. Robust substance abuse treatment, including for opioid use disorder, and mental health access are crucial for student environmental health in Norway.
Abstract
Background and Aims: Several studies have pointed to relatively high levels of illicit drug use among students in higher education compared to the ...
Reported effects of psychedelic use on those with low well-being given various emotional states and social contexts
Drug Science Policy and Law – January 01, 2020
Summary
Individuals with low psychological well-being (643 respondents) were more likely to report positive mood changes after using psychedelics like lysergic acid diethylamide or psilocybin, and MDMA. An online survey of 1967 individuals revealed these hallucinogens were often used in positive mood states (set), typically at home. Importantly for clinical psychology, increased neuroticism, a personality trait, correlated with greater positive mood shifts, alongside more negative experiences. This highlights potential for psychiatry in Psychedelics and Drug Studies.
Abstract
Background It has been suggested that the outcome of the psychedelic experience is dependent on set and setting. While scientific research into the...
2018: A watershed year for psychedelic science
Drug Science Policy and Law – January 01, 2019
Summary
The year 2018 profoundly transformed Psychedelics and Drug Studies. A key acknowledgement came when the Food and Drug Administration designated psilocybin-assisted psychotherapy a "breakthrough therapy" for depression. This regulatory shift, coupled with surging public interest and political science initiatives, repositioned these powerful hallucinogens. The momentum ignited diverse academic research themes, spanning psychology, social science, and even environmental ethics, solidifying the field's long-term outlook beyond just chemical synthesis and alkaloids.
Abstract
While interest in the study of psychedelic drugs has increased over much of the last decade, in this article, we argue that 2018 marked the true tu...
Serotonin, psychedelics and psychiatry
World Psychiatry – September 07, 2018
Summary
In Psychiatry, just one or two psychedelic treatment sessions can yield therapeutic effects lasting several months for mood disorders and addiction—an unprecedented outcome. Neuropsychopharmacology reveals Serotonin's complex role, with 5-HT2A neurotransmitter receptor influence on behavior being key to the "psychedelic experience" and heightened context sensitivity. This shift in Medicine and Drug Studies, moving beyond traditional psychoanalysis and simple Serotonin deficiency models, highlights new Psychology avenues exploring how these compounds, often alkaloids, profoundly impact mental health.
Abstract
Serotonin is a key neuromodulator known to be involved in brain development, perception, cognition, and mood. However, unlike as with dopamine for ...
Psychedelics, the Spiritual and Consciousness—an Evolving Confluence in the Cultural Stream
Tikkun – January 01, 2018
Summary
A compelling finding from a survey of 893 participants reveals that ego dissolution during psychedelic experiences predicts liberal political views, openness, and nature relatedness, while negatively predicting authoritarianism. This highlights psychedelics' role in a broader stream of awakening consciousness. Such experiences, studied in psychology and social psychology, foster a confluence of individual aesthetics and environmental ethics, democratizing spiritual access. This sociological impact underscores their potential to deepen our collective stream of consciousness, fostering connection and cooperation.
Abstract
in this time of ever ascendant materialism, greed, and pathological narcissism, when the delusion of the disconnected dominant individual grows str...
Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness
Journal of Psychopharmacology – June 20, 2017
Summary
Experience with classic hallucinogens like psilocybin and mescaline strongly predicts pro-environmental behavior, a compelling Psychology finding from a 1,487-person general population study. This effect, relevant to social psychology, is explained by a deeper self-identification with nature, independent of Big Five personality traits such as conscientiousness or openness to experience. These Psychedelics and Drug Studies highlight how neurotransmitter receptor influence on behavior can foster ecological conscientiousness, suggesting unique societal benefits beyond individual mental wellbeing.
Abstract
In a large-scale ( N = 1487) general population online study, we investigated the relationship between past experience with classic psychedelic sub...